Skip to content
Aperlena

TED - Tenders Electronic Daily (Publications Office of the EU) verified 1 week ago Contract notice

Germany - Medicinal products - Conclusion of non-exclusive rebate agreements under § 130a para. 8 SGB V from 01.07.2026

Original Deutschland - Arzneimittel - Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V ab dem 01.07.2026

Open Germany Düsseldorf Medical equipment & pharmaceuticals

Buyer GWQ ServicePlus AG

394 days left

Key facts

Closes
10:00 (UTC+1)
Competition
Open race
  1. Published
  2. Today
  3. Deadline was
  4. Deadline open for 526 days
  5. Awarded pending
View the official notice Watch this tender

If the deadline moves or the notice is corrected, we email you. Log in

The Aperlena Verdict

Open race

No supplier dominates: 34 different companies have won the last 39 comparable contracts from this buyer over 5 years. This is a genuinely open race.

Based on 39 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.

Summary

Machine-generated summary

GWQ ServicePlus AG, acting for its shareholder and customer health insurance funds, intends to conclude non-exclusive rebate agreements under § 130a para. 8 SGB V for a named active substance, with contracts starting on 01.07.2026. The procedure is described as an open access model: all interested pharmaceutical companies may join at any time during the contract period on identical terms, with no selection decision. Documents, participating health insurers and deadlines are available on the GWQ procurement portal. Signed contracts and proof of a medicinal product rebate agreement must be submitted by 10.06.2026 to enable first notification on 01.07.2026.

Description

§ 130a Abs. 8 SGB V ermöglicht den Krankenkassen (KK) und pharmazeutischen Unternehmen, Rahmenrabattverträge über die zu Lasten der gesetzlichen KK abzugebenden Arzneimittel zu schließen. Die GWQ wird als Gesellschaft für Wirtschaftlichkeit und Qualität bei KK gem. § 130a Abs. 8 S. 5 SGBV für ihre Aktionärs- und Kundenkassen tätig. In Hinblick auf die dafür einschlägigen gesetzlichen Vorschriften zur Vergabe öffentlicher Aufträge, findet ein regelmäßiger Prozess wirkstoffbezogener, förmlicher Vergabeverfahren nach den Regularien des 4. Teils des GWB durch die GWQ ServicePlus AG statt. Bis zum In Krafttreten neuer Arzneimittelrabattverträge möchte die GWQ mit allen interessierten pharmazeutischen Unternehmen Arzneimittelrabattverträge abschließen. Vertragsstart ist der 01.07.2026. Die GWQ ServicePlus AG beabsichtigt, nichtexklusive Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu dem o. a. Wirkstoff mit Vertragsstart zum 01.07.2026 zu schließen. Diesem Vertrag können zu jeder Zeit der Vertragslaufzeit alle interessierten Unternehmen zu den gleichen Bedingungen beitreten (Zulassungsmodell). Die GWQ geht davon aus, dass dieses Verfahren auf Grund einer fehlenden Auswahlentscheidung und mithin der diskriminierungsfreien Zugangsmöglichkeit aller pharmazeutischen Unternehmen nicht in den Anwendungsbereich des Kartellvergaberechts fällt. Die Vertragsunterlagen, die teilnehmenden Krankenkassen und deren Umsätze sowie die Termine für die Meldung des Vertrags sind auf dem Vergabeportal der GWQ ServicePlus AG unter https://vergabeportal.gwq-serviceplus.de/arzneimittel einzusehen und herunterzuladen. Bis zum Start exklusiver Verträge steht diese Übergangsvereinbarung allen Marktteilnehmern zum Beitritt offen. Bei Eingang der unterzeichneten Verträge / Erklärung und Nachweise zum 10.06.2026 kann eine erstmalige Meldung zum 01.07.2026 realisiert werden. Folgende Unterlagen sind einzureichen: unterzeichneter Vertrag in doppelter Ausfertigung; einen Nachweis über die arzneimittelrechtliche Zulassung mittels Auszug aus dem öffentlichen Teil der AMIceDatenbank; unterzeichnete Eigenerklärung (Anlage 3). Liste der vertragsgegenständlichen PZN (Anlage 4), Eigenerklärung zur EU-Verordnung (Anlage 5); Die GWQ ServicePlus AG beabsichtigt, nichtexklusive Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu dem o. a. Wirkstoff mit Vertragsstart zum 01.09.2026 zu schließen. Diesem Vertrag können zu jeder Zeit der Vertragslaufzeit alle interessierten Unternehmen zu den gleichen Bedingungen beitreten (Zulassungsmodell). Die GWQ geht davon aus, dass dieses Verfahren auf Grund einer fehlenden Auswahlentscheidung und mithin der diskriminierungsfreien Zugangsmöglichkeit aller pharmazeutischen Unternehmen nicht in den Anwendungsbereich des Kartellvergaberechts fällt. Die Vertragsunterlagen, die teilnehmenden Krankenkassen und deren Umsätze sowie die Termine für die Meldung des Vertrags sind auf dem Vergabeportal der GWQ ServicePlus AG unter https://vergabeportal.gwq-serviceplus.de/arzneimittel einzusehen und herunterzuladen. Bis zum Start exklusiver Verträge steht diese Übergangsvereinbarung allen Marktteilnehmern zum Beitritt offen. Bei Eingang der unterzeichneten Verträge / Erklärung und Nachweise zum 10.08.2026 kann eine erstmalige Meldung zum 01.09.2026 realisiert werden. Folgende Unterlagen sind einzureichen: unterzeichneter Vertrag in doppelter Ausfertigung; einen Nachweis über die arzneimittelrechtliche Zulassung mittels Auszug aus dem öffentlichen Teil der AMIceDatenbank; unterzeichnete Eigenerklärung (Anlage 3). Liste der vertragsgegenständlichen PZN (Anlage 4), Eigenerklärung zur EU-Verordnung (Anlage 5)

Bid or no-bid?

Six questions before you commit a team. Under each one, what the register holds on it. The answers are yours.

  1. In your favour:

    Do we meet every eligibility criterion?

    Open procedure: any interested supplier may submit a bid.

    Above the EU threshold: open to companies from any EU country.

  2. Your call:

    Can we deliver this with the team we have?

    The register holds nothing on this. The official documents will.

  3. Your call:

    Do we have two comparable references?

    Comparable work is in Medical equipment & pharmaceuticals.

  4. In your favour:

    Is the deadline realistic for a proper offer?

    394 days left, 283 of them working days.

  5. Your call:

    Is there a margin at the likely winning price?

    This buyer usually awards this kind of contract for between €1 and €1.

  6. In your favour:

    Do we know this buyer?

    34 different companies won the last 39 comparable contracts.

Can I bid?

  • Open procedure: any interested supplier may submit a bid. Above the EU threshold: open to companies from any EU country.
  • The notice is written in German.
  • Certificates from another EU country? Check the equivalents on eCertis

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Report an error in this notice

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 week ago

What this buyer has paid before

Based on 22 comparable contracts this buyer awarded in this sector over the last 4 years.

Median award
€1
Middle half of past awards
€1 to €1

TED - Tenders Electronic Daily (Publications Office of the EU) publishes no value for this notice, so it has no mark on the scale. The official documents may state one.

Most recent awards

Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.

GWQ ServicePlus AG

Germany

notices in the register
96
awards
39

Who wins its contracts

Many suppliers
different companies won its awards
34
of the awards went to the three most frequent winners
15%
of its calls state an estimated value
0%

Based on 39 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)
3.5
of those lots received a single tender
13%
of the awards went to companies based in another country
6%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

Who usually wins this buyer's contracts in this sector

Based on 39 awards with a linked company profile over the last 5 years.

39 open tenders right now

Market context

TED - Tenders Electronic Daily (Publications Office of the EU) publishes no value for this notice, so it cannot be placed among the open notices of its sector. The official documents may state one.

open now in Medical equipment & pharmaceuticals
8,192
median open notice
€303,562

Who wins in this market

Many suppliers

Germany · Medical equipment & pharmaceuticals

different companies won awards here
806
of the awards went to the three most frequent winners
9%
buyers awarded contracts here
447

Based on 1,527 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)
12.2
of those lots received a single tender
16%
of the awards went to companies based in another country
7%
of the tenders came from another country
6%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

Change history

Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.

  1. Act now
    Submission deadline
    Was: November 10, 2027, 00:00
    Now: November 10, 2027, 00:00 1 day earlier
    Scope and criteria
    The description was expanded. Re-read it before you bid.

Follow this tender and we email you the moment it changes. Create account

Similar tenders

Open now

Awarded before

Never miss a tender like this

63 new notices in Medical equipment & pharmaceuticals in Germany in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

Or follow just its CPV code, Pharmaceutical products: an email when new tenders arrive under it, no account needed.

394 days left

Open notice

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
o
Open the result in a new tab
x
Set this result aside
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Index

Close
Log in

Language